Investigating pancreas size and diabetes risk during pregnancy using MRI
Diabetes Prediction During Pregnancy and In Utero Using Pancreas MRI
This study is looking at how the size of the pancreas in pregnant women might affect their chances of developing diabetes, using special MRI scans to see how the pancreas changes over time, and it's for expectant moms, especially those with diabetes or at risk for it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11180323 on NIH RePORTER |
What this research studies
This research explores the relationship between pancreas size and the risk of developing diabetes during and after pregnancy. By using advanced MRI technology, the study aims to noninvasively assess the size and structure of the pancreas in pregnant women, including those with diabetes and those at risk. The research will track changes in pancreas size over time and correlate these changes with the development of diabetes, providing insights into how pancreas growth in fetuses may relate to diabetes risk later in life.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women, particularly those with pregestational type 2 diabetes or those who develop gestational diabetes.
Not a fit: Patients who are not pregnant or those without any risk factors for diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to early identification of women at risk for diabetes during pregnancy, allowing for timely interventions.
How similar studies have performed: Similar research has shown promise in using imaging techniques to assess organ size and function, suggesting potential for success in this novel approach.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Virostko, John Michael — University of Texas at Austin
- Study coordinator: Virostko, John Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.